Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma.

Autor: Ren, L., Ruiz-Rodado, V., Dowdy, T., Huang, S., Issaq, S. H., Beck, J., Wang, H., Tran Hoang, C., Lita, A., Larion, M., LeBlanc, A. K.

Publikováno v: Cancer & Metabolism; 3/5/2020, Vol. 8 Issue 1, p1-13, 13p

Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis.

Autor: Ren L; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hong ES; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Mendoza A; Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Issaq S; Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Tran Hoang C; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Lizardo M; Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., LeBlanc A; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Khanna C; Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Dr. Khanna is currently with Ethos Veterinary Health, Woburn MA and Ethos Discovery, Washington DC, USA.

Publikováno v: Oncotarget [Oncotarget] 2017 Jun 13; Vol. 8 (24), pp. 38541-38553.